FIELD: medicine.
SUBSTANCE: method involves determining potassium concentration in patient saliva before and after the first treatment applied to biologically active points of general systemic activity with electromagnetic radiation in wavelength bandwidth of 3.8-5.6 mm having specific noise power of 1.0-4.0 mcW/cm2. Potassium level dropping 1.3 times as low, therapy effectiveness is to be predicted. The potassium level reduction being less than 1.3 times as low or increase taking place, further treatment ineffectiveness is to be predicted.
EFFECT: high prognosis accuracy.
| Title | Year | Author | Number |
|---|---|---|---|
| EARLY STAGE DIAGNOSIS METHOD FOR PREDICTING MYOCARDIUM NECROSIS IN ACUTE CORONARY SYNDROME PATIENTS | 2005 |
|
RU2293328C2 |
| METHOD FOR TREATING CARDIOVASCULAR DISEASE CASES | 2005 |
|
RU2286185C2 |
| METHOD OF TREATING CARDIOVASCULAR DISEASES | 2012 |
|
RU2536058C2 |
| METHOD OF PREDICTION OF LASER THERAPY EFFICIENCY | 1995 |
|
RU2127617C1 |
| METHOD FOR DIAGNOSING MICROVASCULAR STENOCARDIA IN CASES OF MYOCARDIAL ISCHEMIA DISEASE | 1998 |
|
RU2133467C1 |
| METHOD FOR TREATING ANGINA PECTORIS PATIENTS | 1994 |
|
RU2086269C1 |
| METHOD FOR DETERMINING INDIVIDUAL SENSITIVITY OF PATIENTS AFFECTED WITH ISCHEMIC HEART DISEASE | 1994 |
|
RU2082977C1 |
| METHOD FOR PREDICTING TISSUE INSULIN-RESISTANCE IN DIFFERENT CATEGORIES OF CARDIOLOGIC PATIENTS | 2001 |
|
RU2230326C2 |
| METHOD OF TREATING INITIAL MANIFESTATIONS OF HEART FAILURE WITH LOW-INTENSITY MAGNETIC LASER RADIATION | 2023 |
|
RU2818731C1 |
| METHOD FOR TREATING PATIENTS FOR RESPIRATORY ORGAN SARCOIDOSIS | 2002 |
|
RU2238772C2 |
